Drug catabolism and its significance for pharmacotherapy
Kolenda, K.D.
Medizinische Klinik 75(7): 240-250
1980
ISSN/ISBN: 0025-8458 PMID: 6771507 Document Number: 154824
Document emailed within 1 workday
Related Documents
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64Wiela-Hojeńska, A.; Orzechowska-Juzwenko, K. 2003: Bioavailability and its significance in pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(79): 89-93
Schlicht, I.; Schulte-Hermann, R.; Koransky, W.; Eulenstedt, C. 1972: Foreign material induced liver growth and regeneration under the influence of drug catabolism inhibitors Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1362-1365
Orzechowska-Juzwenko, K. 1987: Monitored pharmacotherapy and factors changing drug kinetics in the body Polski Tygodnik Lekarski 42(51-52): 1623-1627
Jabłecka, A.; Korzeniowska, K. 2010: The safety of pharmacotherapy in the light of monitoring adverse drug reaction Przeglad Lekarski 67(10): 1091-1092
Danysz, A. 1977: Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy Polski Tygodnik Lekarski 32(52): 2057-2060
Cernohorský, M.; Elisová, K.; Cepelík, J.; Lövy, O.; Elis, J. 1980: Retrospective analysis of pharmacotherapy in 20 in-patient medical departments with regard to potential drug interactions Casopis Lekaru Ceskych 119(25-26): 725-730
Reddy, S.M.; Sinha, V.R.; Reddy, D.S. 1999: Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs Drugs of Today 35(7): 537-580
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506
Kordus, K.; Spiewak, Rław. 2013: Pharmacotherapy of atopic eczema--an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs Przeglad Lekarski 70(12): 1021-1026
Giesecke, H.; Meyer, F.P.; Walther, H. 1975: Problems of ambulatory pharmacotherapy. 6. Studies of the ambulatory pharmacotherapy of influenza Zeitschrift für Arztliche Fortbildung 69(23): 1201-1208
Talbert, R.L.; Gal, P.; Dukes, G.E.; Miller, W.A.; Porter, W.C.; Rush, D.R.; Schneider, P.; Vlasses, P.H.; Zarowitz, B.J. 1992: Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on Pharmacotherapy PharmacoTherapy 12(6): 484-490
Rodríguez Terol, A.; Santos Ramos, B.; Caraballo Camacho, M.; Ollero Baturone, M. 2008: Clinical significance of drug interactions Medicina clinica 130(19): 758-9; author reply 759
Hoque, M.Monjurul.; Hossain, K.Jahangir.; Kamal, M.Mustafa.; Akhtaruzzaman, M. 2009: Naltrexone in drug addiction: significance in the prevention of relapse Mymensingh Medical Journal: Mmj 18(1 Suppl): S56-S65
Cripps, G.W.; Martinez, D.R.; Gilliam, R.A.; Caldwell, T.J. 1973: Significance of drug-altered laboratory test values American Journal of Hospital Pharmacy 30(7): 603-606
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Yoshikawa, H. 1989: Clinical application and significance of drug delivery systems. Cytokine Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1324-1328
Stricker, B.H.; Rosendaal, F.R. 1995: Significance of pharmacoepidemiology for drug monitoring and quality of care: the pill Nederlands Tijdschrift Voor Geneeskunde 139(49): 2541-2543
Golanov, V.S.; Bogdalova, V.E.; Andreev, L.P.; Losin, E.I.; Ushakova, A.G.; Meshcheriakov, V.G.; Bondin, S.V. 1991: Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms Problemy Tuberkuleza 12: 27-28
Trnavská, Z.; Verner, P. 1983: The binding of drugs to proteins. I. General significance for drug kinetics Ceskoslovenska Farmacie 32(2): 88-95